The Best of the Coronavirus Blog This Week
Welcome to the fall surge
The latest vaccine news. This week, Johnson & Johnson and Novavax’s Covid-19 vaccine candidates advanced to the final stages of clinical trials, which brings the number of vaccines in phase 3 trials to 11. Johnson & Johnson’s vaccine may have an advantage over its competitors because it could need only one shot instead of two and doesn’t have to be kept frozen. Read more news from the vaccine race below.